Wong A, Nolan S, Bach P, Janssen RM, De Wolfe TJ, Dickhout P, Beauchesne R, Yang F, Johnson C, Carter A, Nosyk B, Dennis BB Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: a case series Drug Alcohol Depend Rep PubMed

Socías ME, Lei J, Zhou V, Anand R, Cui Z, Penta S, Larochelle MR, Lodi S, Fairbairn N Slow-release oral morphine vs methadone for opioid use disorder in the fentanyl era JAMA Netw Open PubMed

Mihic T, Socías ME, McCrae K, Johnson C, Nolan S, Grant C, Sutherland C, Fairbairn N Community pharmacy-based injectable opioid agonist treatment: findings from a Canadian pilot program Drug Alcohol Rev PubMed

Hayashi K, Reading D, Bach P, Choi JC, Hedden L, Milloy MJ, DeBeck K Engagement with and acceptability of telephone-based telemedicine in addiction care in Vancouver, Canada, 2020–2023 J Addict Med Link

Bozinoff N, Lei J, Mihic T, Moe J, Palis H, Nolan S, Ti L, Kennedy MC Uptake of low-dose buprenorphine initiation and associated patient characteristics in British Columbia, Canada: a population-based cohort study J Addict Med PubMed

Socías ME, Dickhout P, Langlois J, Grant C, Nolan S Extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: the FASTER-BUP udy [sic] Drug Alcohol Depend PubMed

Jackson E, Bach P, Socías ME, Brooks OM, Fairbairn N, Rodrigues M, Rosic T, Naji L, Jinks-Chang S, Nolan S, Chesney A, Reshetukha T, Samaan Z, Dennis B Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: findings from a prospective cohort study from 2013 to 2020 Drug Alcohol Depend PubMed

Mayer S, Fairbairn N, Fowler A, Boyd J, Kerr T, McNeil R Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada Harm Reduct J PubMed

Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME Comparative effectiveness of buprenorphine/naloxone and methadone on methamphetamine/amphetamine use among people with opioid use disorder in Canada Subst Use Addctn J PubMed